A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Nov. 30, 2023 — Slow waves that usually only occur in the brain during sleep are also present during wakefulness in people with epilepsy and may protect against increased brain excitability ...

over the past decade epilepsy researchers have increasingly discussed and promoted the concept of targeting underlying brain mechanisms of epileptogenesis and injury that cause epilepsy and its ...

Sensorium Therapeutics, a biotechnology company developing novel, first-in-class medicines to treat a variety of CNS diseases, announced it presented positive preclinical data on lead programs SENS-01 ...

We often only realize how important our sense of smell is when it is no longer there: food hardly tastes good, or we no ...

The largest and most diverse study to date of epilepsy's genetic factors has revealed new potential targets for treatment, ...

The largest study of its kind has identified individual genes, gene sets, and gene variants that increase risk of developing ...

a novel chemical entity with a differentiated mechanism of action to address focal onset seizures for drug-resistant epilepsy patients, at Neuroscience 2024. The company also shared details on the ...

It is reasonable to hypothesize that the same mechanisms that account for normal synaptic plasticity might also mediate pathophysiological changes in dendrites with epilepsy, but in a more extreme ...

lamotrigine (Lamictal): A broad-spectrum alternative to VPA, with a better side effect profile. However, LTG may not be as effective for myoclonic seizures. Lamotrigine works by several mechanisms ...

Vimpat (lacosamide) can help manage focal seizures in adults and children 4 years and older. It can be used alone (monotherapy) or with another AED (adjunctive therapy). Lacosamide reduces the amount ...